Frequency of infection by hepatitis B virus and its surface mutants in a northern Indian population

Indian Journal of Gastroenterology

Volumn 22, Issue 4, 2003, Pages 132-137

  Singh, Harjeet ^a   Aggarwal, Rakesh ^a   Singh, R L ^b   Naik, S R ^a   Naik, Sita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Epidemiology; Variants

Indexed keywords

AMINO ACID; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD TRANSFUSION; CYTOTOXIC T LYMPHOCYTE; EXPOSURE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RURAL POPULATION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; URBAN POPULATION; VIRUS CARRIER; VIRUS MUTANT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; MUTATION; SEROEPIDEMIOLOGIC STUDIES;

EID: 0042733355     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Thyagarajan SP, Jayaram S, Mohanavalli B. Prevalence of HBV in general population of India. In: Sarin SK, Singal AK, Eds. Hepatitis B in India: Problems and Prevention. New Delhi: CBS. 1996: p. 5-16.
2. Makroo RN, Hassain G, Koul A, Shah GN. Prevalence of hepatitis B surface antigen in Kashmiri blood donors. Indian J Med Res 1989;89:310-3.
3. Elavia AJ, Banker DD. Prevalence of hepatitis B surface antigen and its subtypes in high risk group subjects and voluntary blood donors in Bombay. Indian J Med Res 1991;93:280-5.
4. Prasad SR, Rodrigues FM, Dhorje SP, Ramamoorthy CL. Prevalence and subtypes of hepatitis B surface antigen in the tribal population of Arunachal Pradesh, India. Indian J Med Res 1983;78:300-6.
5. Reddy PH, Tedder RS. Hepatitis virus markers in the Baiga tribal population of Madhya Pradesh, India. Trans R Soc Trop Med Hyg 1995;89:620.
6. Mukherjee M, Joshi SH, Rao VR, Gorakshakar AC, Sathe MS. Prevalence of hepatitis B surface antigen among some tribes of Madhya Pradesh and Maharashtra. J Indian Anthrop Soc 1990;25:68-72.
7. Murhekar MV, Murhekar KM, Das D, Arankalle VA, Sehgal SC. Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands. Indian J Med Res 2000;111:199-203.
8. Chowdhury A, Santra A, Chaudhuri S, Ghosh A, Banerjee P, Mazumder DN. Prevalence of hepatitis B infection in the general population: a rural community based study. Trop Gastroenterol 1999;20:75-7.
9. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987;21:137-45.
10. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
11. Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat 1998;5(Suppl 2):17-23.
12. Keller GH, Cumming CU, Huang DP, Manak MM, Ting R. A chemical method for introducing haptens onto DNA probes. Anal Biochem 1988;170:441-50.
13. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht H-J, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659-71.
14. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001;33:963-71.
15. Stuyver LJ, Locarninin SA, Lok A, Richman DD, Carman WF, Dienstag JL, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751-7.
16. Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996;38 (Suppl 2):S31-S36.
17. Torres JR. Hepatitis B and hepatitis delta virus infection in South America. Gut 1996;38(Suppl 2):S48-55.
18. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989;1:889-93.
19. Johnson CJ, Anderson H, Spearman J, Madson J. Ear piercing and hepatitis. Nonsterile instruments for ear piercing and the subsequent onset of viral hepatitis. JAMA 1974;227:1165.
20. Limentani AE, Elliott LM, Noah ND, Lamborn JK. An outbreak of hepatitis B from tattooing. Lancet 1979;2:86-8.
21. Abdool Karim SS, Coovadia HM, Windsor IM, Thejpal R, van den Ende J, Fouche A. The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa. Int J Epidemiol 1988;17:168-73.
22. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999;77:801-7.
23. Singh J, Bhatia R, Gandhi JC, Kaswekar AP, Khare S, Patel SB, et al. Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bull WHO 1998;76:93-8.
24. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163:397-9.
25. Lai ME, Farci P, Figus A, Balestrieri A, Amone M, Vyas GN. Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood 1989;73:17-9.
26. Driss F, Boboc B, Zarski JP, Cals MJ, Pol S, Eme D, et al. An epidemiological and clinical study of transaminase levels and hepatitis B antibodies in 1,100 blood donors. Vox Sang 1989;57:43-8.
27. Nagaraju K, Mishra S, Saraswat S, Choudhary N, Masih B, Ramesh V, et al. High prevalence of HBV infectivity in blood donors detected by dot-blot hybridization assay. Vox Sang 1994;67:117-24.
28. Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 1999;180:1444-51.
29. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407-10.
30. Ogata N, Zannetti AR, Yu M, Miller RH, Purcell RH. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerges in a vaccinated infant. J Infect Dis 1997;175:511-23.
31. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-7.